Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Product Development

FDA expanding U.S. COVID-19 test capacity, industry ramping up to meet demand

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

March 17, 2020 9:54 PM UTC
Updated on Mar 25, 2020 at 7:36 PM UTC

The U.S. FDA Monday night announced new policies and Emergency Use Authorizations to expand COVID-19 test capacity.

Diagnostics companies are also stepping up to meet demand. Qiagen is increasing production of RNA extraction kits, and more companies are seeking and obtaining authorization to offer tests. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article